Medicare Enrolled
Dr. Pamela Reyes Guerrero, M.D.
Internal Medicine · Winter Haven, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reyes Guerrero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reyes Guerrero?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reyes Guerrero
Dr. Pamela Reyes Guerrero is an internal medicine specialist in Winter Haven, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Reyes Guerrero performed 11,139 Medicare services across 5,554 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reyes Guerrero received a total of $10,764 from 51 pharmaceutical and/or device companies across 543 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reyes Guerrero is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 3% volume in FL
$10,764 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 122228 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗11,139
Medicare services
Top 3% in FL for internal medicine
5,554
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~796 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,200 | $18 | $39 |
| Contrast dye for imaging (iodine-based) | 1,050 | $0 | $0 |
| Blood draw (venipuncture) | 767 | $8 | $9 |
| Complete blood count (CBC) with differential | 674 | $8 | $16 |
| Thyroid stimulating hormone (TSH) test | 653 | $16 | $34 |
| Office visit, established patient (30-39 min) | 604 | $87 | $218 |
| Urine microalbumin test (kidney screening) | 565 | $6 | $12 |
| Creatinine test (kidney function) | 562 | $5 | $10 |
| Hemoglobin A1c test (diabetes monitoring) | 469 | $9 | $19 |
| Office visit, established patient (20-29 min) | 456 | $65 | $150 |
| Comprehensive metabolic blood panel | 348 | $10 | $21 |
| Kidney function blood test panel | 329 | $9 | $17 |
| Annual wellness visit, follow-up | 271 | $126 | $231 |
| Lipid panel (cholesterol and triglycerides) | 258 | $13 | $27 |
| Urinalysis using microscope | 214 | $3 | $6 |
| Urinalysis with microscopic exam | 211 | $3 | $6 |
| Automated urinalysis | 209 | $2 | $4 |
| Urine culture, bacterial identification | 164 | $8 | $34 |
| Annual depression screening | 145 | $18 | $36 |
| Drug injection, under skin or into muscle | 143 | $10 | $42 |
| Prothrombin time test (blood clotting) | 124 | $4 | $9 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 117 | $16 | $45 |
| Urine culture, bacterial colony count | 103 | $8 | $34 |
| Dexamethasone injection (steroid) | 90 | $0 | $0 |
| Screening mammography | 73 | $123 | $371 |
| Flu vaccine administration | 73 | $18 | $18 |
| Detection test by immunoassay with direct visual observation for influenza virus | 72 | $16 | $33 |
| Flu vaccine, high-dose | 70 | $72 | $183 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 70 | $1 | $4 |
| 3D screening mammography (tomosynthesis) | 67 | $51 | $154 |
| Chest X-ray, 2 views | 59 | $22 | $96 |
| Injection, ketorolac tromethamine, per 15 mg | 56 | $0 | $1 |
| Transitional care management services for problem of high complexity | 54 | $209 | $487 |
| Electrocardiogram (EKG), 12-lead | 49 | $9 | $51 |
| Parathyroid hormone level test | 44 | $40 | $83 |
| Vitamin B-12 level test | 41 | $15 | $30 |
| Ferritin level test (iron stores) | 41 | $13 | $27 |
| Iron level test | 41 | $6 | $13 |
| Transferrin (iron binding protein) level | 41 | $12 | $26 |
| Thyroxine (thyroid chemical), total | 39 | $7 | $14 |
| Thyroid hormone evaluation | 39 | $6 | $13 |
| Administration of vaccine | 37 | $10 | $42 |
| Bone density scan (DEXA) | 36 | $36 | $116 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 36 | $35 | $90 |
| Office visit, established patient, complex (40-54 min) | 31 | $134 | $294 |
| Vitamin D level test | 28 | $29 | $59 |
| Prostate cancer screening; prostate specific antigen test (psa) | 27 | $19 | $39 |
| Uric acid level test | 22 | $4 | $9 |
| Blood creatinine level | 18 | $5 | $10 |
| Urea nitrogen level to assess kidney function, quantitative | 18 | $4 | $8 |
| New patient office visit (45-59 min) | 18 | $109 | $333 |
| Pneumonia vaccine administration | 18 | $30 | $56 |
| Sed rate test (inflammation marker) | 16 | $3 | $5 |
| Imaging of retina with remote review by physician | 16 | $18 | $101 |
| Complete ultrasound scan behind abdominal cavity | 14 | $80 | $333 |
| Coagulation assessment blood test, plasma or whole blood | 14 | $6 | $12 |
| Transitional care management services for problem of at least moderate complexity | 14 | $158 | $368 |
| Shoulder X-ray, 2+ views | 13 | $23 | $97 |
| Bilirubin level, direct | 13 | $5 | $10 |
| Folic acid level test | 13 | $14 | $29 |
| Hip X-ray, 2-3 views | 12 | $33 | $132 |
| Ultrasound scan of head and neck soft tissue | 12 | $70 | $340 |
| Liver function blood test panel | 12 | $8 | $16 |
| Phosphate level test | 12 | $5 | $9 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $40 | $107 |
| X-ray of lower and sacral spine, minimum of 4 views | 11 | $32 | $142 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $16 | $33 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,764
Total received (2018-2024)
Avg $1,538/year across 7 years
Top 7% in FL for internal medicine
51
Companies
543
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,434 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$330 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$979
2023
$881
2022
$721
2021
$1,483
2020
$1,935
2019
$2,467
2018
$2,298
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,388
AstraZeneca Pharmaceuticals LP
$1,256
Novo Nordisk Inc
$825
Lilly USA, LLC
$648
Amgen Inc.
$646
PFIZER INC.
$630
Boehringer Ingelheim Pharmaceuticals, Inc.
$591
Actelion Pharmaceuticals US, Inc.
$486
SANOFI-AVENTIS U.S. LLC
$388
AbbVie Inc.
$328
Astellas Pharma US Inc
$302
Janssen Pharmaceuticals, Inc
$250
ABBVIE INC.
$225
Abbott Laboratories
$185
Merck Sharp & Dohme Corporation
$184
Allergan Inc.
$180
Allergan, Inc.
$174
Novartis Pharmaceuticals Corporation
$170
Kowa Pharmaceuticals America, Inc.
$151
E.R. Squibb & Sons, L.L.C.
$130
Genentech USA, Inc.
$123
Biohaven Pharmaceutical Holding Company Ltd.
$122
Esperion Therapeutics, Inc.
$110
Boston Scientific Corporation
$101
EMD Serono, Inc.
$98
PORTOLA PHARMACEUTICALS, INC.
$94
United Therapeutics Corporation
$94
Bayer Healthcare Pharmaceuticals Inc.
$92
Amarin Pharma Inc.
$84
Exact Sciences Corporation
$72
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$69
Merck Sharp & Dohme LLC
$67
Biohaven Pharmaceuticals, Inc.
$59
Daiichi Sankyo Inc.
$58
Teva Pharmaceuticals USA, Inc.
$46
Xeris Pharmaceuticals, Inc.
$45
Bayer HealthCare Pharmaceuticals Inc.
$40
Eisai Inc.
$23
Averitas Pharma Inc.
$22
Mylan Specialty L.P.
$22
Aurinia Pharma U.S., Inc.
$20
Smith+Nephew, Inc.
$19
Nestle HealthCare Nutrition Inc.
$18
Phathom Pharmaceuticals, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$18
DEXCOM, INC.
$17
Nabriva Therapeutics, plc
$17
Ironwood Pharmaceuticals, Inc
$16
IMPEL PHARMACEUTICALS INC.
$15
Shire North American Group Inc
$15
SHIELD THERAPEUTICS INC
$13
Top 3 companies account for 32.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CHANTIX · COLOGUARD · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DUZALLO · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVKEEZA · Esbriet · FARXIGA · FORTEO · FREESTYLE LIBRE · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOKELMA · LUPKYNIS · LYRICA · Leqembi · Livalo · MOUNJARO · MYRBETRIQ · Mavenclad · NEXLETOL · NONE · NURTEC ODT · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Otezla · Ozempic · PAXLOVID · PRALUENT · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUTENZA · RENASYS GO v2 HOME · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trudhesa · UBRELVY · UPTRAVI · VERQUVO · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · VYNDAQEL · VYVANSE · Vascepa · Victoza · WATCHMAN · XARELTO · XIFAXAN · Xenleta · Xofluza · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in FL.
Equivalent to $97 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
274
Per 100K population
36.0
County median income
$63,644
Nearest hospital
WINTER HAVEN HOSPITAL
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reyes Guerrero is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement in the top 7% of FL peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reyes Guerrero experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Reyes Guerrero performed 1,200 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reyes Guerrero receive payments from pharmaceutical companies?
Yes. Dr. Reyes Guerrero received a total of $10,764 from 51 companies across 543 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reyes Guerrero's costs compare to other internal medicine physicians in Winter Haven?
Dr. Reyes Guerrero's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reyes Guerrero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Winter Haven
Browse internal medicine physicians in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology